Free US stock cash flow analysis and free cash flow yield calculations to identify companies returning value to shareholders through dividends and buybacks. Our cash flow research helps you find companies with the financial flexibility to grow their business and return capital to investors. We provide cash flow statements, free cash flow yields, and dividend sustainability analysis for comprehensive coverage. Find cash-generating companies with our comprehensive cash flow analysis and yield calculation tools for income investing.
Oramed Pharmaceuticals (ORMP) is trading near the lower end of its recent range at $4.70, a modest 0.74% decline, as the stock continues to consolidate between support at $4.46 and resistance at $4.94. Trading activity this month has been characterized by below-average volume, suggesting a wait-and-
Oramed Pharmaceuticals (ORMP) Stock: Slides -0.74%, Support at $4.46 2026-05-15 - MA Crossover
ORMP - Stock Analysis
4391 Comments
1106 Likes
1
Olaniyan
Daily Reader
2 hours ago
I don’t know what’s happening but I’m here.
👍 21
Reply
2
Dorth
Regular Reader
5 hours ago
Expert US stock price momentum and mean reversion analysis for timing strategies. We analyze historical patterns of how stocks behave after different types of price movements.
👍 264
Reply
3
Chardonnae
Consistent User
1 day ago
Key indices are approaching resistance zones — monitor closely.
👍 79
Reply
4
Kaviona
Influential Reader
1 day ago
Market participants remain vigilant, watching key technical indicators and economic announcements closely.
👍 136
Reply
5
Semih
Active Reader
2 days ago
Indices are testing support levels, which may provide a base for potential upward moves.
👍 226
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.